TYMS and colorectal carcinoma: It has been suggested that resistance to 5FU chemotherapy cannot be assigned solely to TS or p53 expression [40] rather, markers associated with the cell cycle should be included in the search for predictive markers of benefit for 5FU-based chemotherapy in CRC [12].